CD262 (DR5) Antibody 14-9908-82 from Thermo Fisher Scientific

Product Specs
ItemCD262 (DR5) Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number14-9908-82
Quantity100 µg
ApplicationsFlow Cytometry, Immunocytochemistry
Concentration0.5 mg/mL
Conjugate/TagUnconjugated
FormatPBS with 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD262 (DR5)
IsotypeIgG1 kappa
CloneDJR2-4 (7-8)
HostMouse
NCBI Full Gene NameTNF receptor superfamily member 10b
NCBI Gene AliasesCD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C
Antibody TypePrimary
Storage4° C

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(1) Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localizationeLifeAugust 3, 2021Greenlee JD, Lopez-Cavestany M, Ortiz-Otero N, Liu K, Subramanian T, Cagir B, King MR.(1:50 IF) Antibody,Mouse anti-human CD262 (DR5) Monoclonal Antibody (clone DJR2-4),Invitrogen,Cat# 14-9908-82,RRID:AB_468592 (1:50 IF) Antibody,Alexa Fluor 555 goat anti-mouse IgG (H+L),Invitrogen,Cat# A28180,RRID:AB_2536164

(3) RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancerCell death & diseaseOctober 29, 2020Khawaja H, Campbell A, Roberts JZ, Javadi A, O'Reilly P, McArt D, Allen WL, Majkut J, Rehm M, Bardelli A, et al.

(5) Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosisCell death discoveryJanuary 1, 2016Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV.

(6) Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse ModelsClinical cancer research : an official journal of the American Association for Cancer ResearchDecember 1, 2015Liu Y, Hawkins OE, Vilgelm AE, Pawlikowski JS, Ecsedy JA, Sosman JA, Kelley MC, Richmond A.

(7) TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroidsPloS oneJanuary 1, 2014Chandrasekaran S, Marshall JR, Messing JA, Hsu JW, King MR.

(8) MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cellsPloS oneJanuary 1, 2013Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, et al.

(10) A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosisProceedings of the National Academy of Sciences of the United States of AmericaOctober 25, 2011Dompe N, Rivers CS, Li L, Cordes S, Schwickart M, Punnoose EA, Amler L, Seshagiri S, Tang J, Modrusan Z, et al.

ICC/IF